Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Influenza, Human 15Neoplasms 7Leukemia, Lymphocytic, Chronic, B-Cell 5Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma 3Leukemia 3Colorectal Neoplasms 3Neoplasms, Plasma Cell 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Hodgkin Disease 2Central Nervous System Neoplasms 2Anemia, Aplastic 2Waldenstrom Macroglobulinemia 1Vaccine-Preventable Diseases 1Vaccination Hesitancy 1Skin Neoplasms 1Sezary Syndrome 1Serology Analysis 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Primary Myelofibrosis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Patient Acceptance of Health Care 1Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 6Granulocyte Colony-Stimulating Factor 5Melphalan 4Etoposide 4Cisplatin 4Carboplatin 4sodium thiosulfate 3fludarabine 3Thiotepa 3Mesna 3Filgrastim 3Busulfan 3pembrolizumab 2Vorinostat 2Vincristine 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Ifosfamide 2Gemcitabine 2Fluorouracil 2Doxorubicin 2talazoparib 1sintilimab 1sargramostim 1pegylated granulocyte colony-stimulating factor 1omburtamab I-131 1lenvatinib 1irinotecan sucrosofate 1fludarabine phosphate 1etoposide phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hepatoblastoma × Influenza Vaccines × Clear all
NCT01804634 2026-03-13

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
60 enrolled
CNSGastrointestinalSarcoma

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡